Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation
Abstract
No abstract availableKeywords
Funding Information
- Immune System Activation (ISA) Pharmaceuticals
- Leiden University Medical Center
This publication has 63 references indexed in Scilit:
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletionNature Medicine, 2013
- Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein AntigenThe Journal of Immunology, 2012
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery AspectsInternational Journal of Molecular Sciences, 2010
- Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responsesExpert Review of Vaccines, 2010
- The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cellsBiomaterials, 2009
- Innovative strategies for co-delivering antigens and CpG oligonucleotidesAdvanced Drug Delivery Reviews, 2009
- Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasomeProceedings of the National Academy of Sciences, 2009
- Antigen kinetics determines immune reactivityProceedings of the National Academy of Sciences, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007